Keyphrases
Cholera
62%
Oral Cholera Vaccine
29%
Zambia
17%
Second Dose
14%
Cameroon
12%
Far North Region of Cameroon
11%
COVID-19
11%
Shigella
11%
Bangladesh
11%
Rapid Diagnostic Test
10%
Antibody Response
9%
Vaccine Effectiveness
8%
Dose Rate
8%
Vaccination
8%
Specimen Preservation
7%
Epidemiology
7%
Neutralizing Antibodies
7%
Diarrhea
7%
Filter Paper
7%
Vibriocidal
7%
Mass Vaccination
7%
Stool Specimen
7%
Whatman
7%
Vibrio Cholerae O1
7%
Confidence Interval
6%
Polymerase Chain Reaction
6%
Africa
6%
Ring Vaccination
6%
Stool Samples
6%
COVID-19 Vaccine
6%
Lusaka
6%
Eastern Democratic Republic of Congo
6%
Cluster Randomized Trial
5%
Community-based Survey
5%
Transmission Events
5%
COVID-19 mRNA Vaccine
5%
Democratic Republic of Congo
5%
Rapid Test
5%
Fatal Outcome
5%
Messenger RNA (mRNA)
5%
One Dose
5%
Lytic Bacteriophage
5%
Diagnostic Algorithm
5%
Enrichment Step
5%
Replication Protein A
5%
Lake Chad Basin
5%
Age-stratified
5%
Prediction Model
5%
Vaccination Strategy
5%
Control Plan
5%
Medicine and Dentistry
Cholera
100%
Cholera Vaccine
24%
Infection
21%
COVID-19
19%
Health Care
17%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Case-Control Study
13%
Health Care Cost
10%
Single Drug Dose
8%
Diarrhea
8%
Cohort Effect
6%
Mass Immunization
6%
Polymerase Chain Reaction
6%
Disease
6%
Public Health
6%
Randomized Clinical Trial
5%
Cost-Effectiveness Analysis
5%
Rapid Diagnostic Test
5%
High Risk Behavior
5%
Newborn Morbidity
5%
Frailty
5%
Immunoglobulin
5%
Ritonavir
5%
Antibody Response
5%
Surface Water
5%
Vibrio Cholerae
5%
Neutralizing Antibody
5%
Cholera Rapid Test
5%
Diagnosis
5%
Vital Capacity
5%
Newborn Mortality
5%
DNA Extraction
5%
Cohort Analysis
5%
Systematic Review
5%
Shigella
5%
Nirmatrelvir
5%
Peptone
5%
Immunology and Microbiology
Vaccine Efficacy
29%
Vibrio Cholerae
26%
Polymerase Chain Reaction
17%
Whole Genome Sequencing
17%
Cholera Vaccine
17%
Infectious Agent
15%
Vibrio Cholerae O1
13%
Spike
12%
Surface Property
11%
Monospecific Antibody
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Antibody Response
11%
Vaccination Policy
10%
DNA Extraction
8%
Neutralization
8%
Titer
8%
Omicron Coronavirus Variant
7%
Replication Factor A
5%
Seroprevalence
5%
Shigella
5%
Case Fatality Rate
5%
Seropositivity
5%
Cladistics
5%
Lineages
5%
Room Temperature
5%
Antibiotic Sensitivity
5%
Simian Virus 40
5%
COVID-19
5%
Inflammatory Arthritis
5%
Anthrax Vaccine Adsorbed
5%
Enteropathogen
5%
Bacteriophage
5%
Adaptive Immune System
5%
Serotype
5%
Immunogenicity
5%
Vital Capacity
5%
Intravenous Immunoglobulin
5%
Enterotoxin
5%
Genetic Variability
5%
